ferrantraite/E+ via Getty Images
Are You a Man or a Mouse?
Nothing takes more confidence than going into the eye of the storm where risks are emerging, the sky is falling, and optimism is nowhere to be found. Over the past several
Alexandria Real Estate Is In Trouble And I'm Ready To Buy
Summary
- ARE is a leading REIT in life science properties, facing challenges due to a downturn in the life science market.
- ARE's shares have dropped 55% from their peak but continue to grow FFO per share.
- ARE's strategic moves include a $500 million share repurchase plan.
- We explore one of ARE's key markets in depth.
REITer's Digest
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in ARE over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.